Workiva and Persefoni Partner to Streamline Investor-Grade Carbon Disclosure Data
Workiva Inc. (NYSE:WK), the world’s leading platform for regulatory, financial and ESG reporting, and Persefoni, Inc., the leading Climate Management and Accounting SaaS Platform helping enterprises and financial institutions easily calculate, analyze, manage, and report their real-time carbon footprint, today announced a strategic partnership to provide transparent, investor-grade carbon disclosures seamlessly to joint customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220216005287/en/
The SEC and other global regulators are announcing new climate-related disclosure guidelines that will impact organizations in a pervasive way. CFOs, sustainability leaders, and their boards will need to collaborate to incorporate carbon reporting requirements of a revised regulatory framework into daily respective operations.
The partnership establishes the only reporting solution in the market that unifies transparent and connected financial and environmental, social and governance (ESG) reporting with deeper granularity around greenhouse gas accounting in accordance with the greenhouse gas protocols (GHGP) to track carbon emissions in Scope 1, indirect emissions in Scope 2, and upstream and downstream emissions in Scope 3.
“Workiva continues to develop and deliver innovative capabilities that ensure our end-to-end platform enables our customers to meet evolving ESG disclosure requirements,” said Julie Iskow, chief operating officer of Workiva. “By partnering with Persefoni, we're able to deliver investor and board-grade carbon data that can be used to make better decisions for businesses and the environment.”
A technology-enabled solution is critical to an organization becoming compliant and thereafter maintaining compliance with regulation. Workiva and Persefoni will jointly offer a connected reporting solution to seamlessly transfer carbon data between the two platforms, empowering users to pivot away from disparate spreadsheets and manual processes. This will allow users to save time, increase efficiency, and reduce complexity and risk. It will also improve overall accuracy and transparency in the record-to-report process.
“We’re excited about the value our partnership will create for our joint customers by easing the path to satisfying complex climate-related disclosure requirements,” said Kentaro Kawamori, chief executive officer of Persefoni. “Together, Workiva and Persefoni become the market leader at simplifying complex ESG and Financial filings, both today and into the future.”
The Technology Behind the Partnership:
Persefoni radically simplifies the technical barrier to entry for carbon accounting, having successfully codified the 750+ pages of the GHGP technical guidance into its platform. Additionally, Persefoni is the first and only vendor to codify the global standard for financed emissions calculations, the Partnership for Carbon Accounting Financials. The platform enables users to turn financial, operational, and supply chain data into certified carbon footprint data, greatly reducing complexity and significantly increasing time to insights across multiple climate disclosure and sustainability reporting frameworks.
The Workiva and Persefoni partnership will enable users to seamlessly integrate and transfer data between the companies’ platforms, as well as allow access to carbon benchmarking and a carbon offsets marketplace. These include: activity data, carbon footprint calculations, climate trajectory models, secondary data sets, operational, financial and supply-chain data, and more.
Joint customers will then be able to use the Workiva Framework Explorer to compare data to requirements listed across multiple frameworks, including the United Nations Sustainable Development Goals (UNSDGs), Task Force on Climate-Related Financial Disclosures (TCFD), Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) and Carbon Disclosure Project (CDP), and report outcomes to all stakeholders.
About Workiva
Workiva Inc. (NYSE: WK) simplifies complex work for thousands of organizations worldwide. Customers trust Workiva’s open, intelligent and intuitive platform to connect data, documents and teams. The results: more efficiency, greater transparency and less risk. Learn more at workiva.com.
Read the Workiva blog: www.workiva.com/blog
Follow Workiva on LinkedIn: www.linkedin.com/company/workiva
Like Workiva on Facebook: www.facebook.com/workiva/
Follow Workiva on Twitter: www.twitter.com/Workiva
Follow Workiva on Instagram: www.instagram.com/workiva
About Persefoni
Persefoni, Inc., is the leading Climate Management & Accounting Platform (CMAP). The company's Software-as-a-Service solutions enable enterprises and financial institutions to meet stakeholder and regulatory climate disclosure requirements with the highest degree of trust, transparency, and ease. As the ERP of Carbon, the Persefoni platform provides users a single source of carbon truth across their organization, enabling them to manage their carbon transactions and inventory with the same rigor and confidence as their financial transactions. Learn more at https://persefoni.com.
Follow Persefoni on LinkedIn: https://www.linkedin.com/company/persefoni.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220216005287/en/
Contact information
Media Inquiries:
Kevin McCarthy
Workiva Inc.
(515) 663-4471
press@workiva.com
Media Inquiries:
Susan Koehler
Persefoni, Inc.
press@persefoni.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press Release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom